(Reuters) - Amag Pharmaceuticals Inc said on Thursday chief executive officer would step down and it plans to divest two of its women's health drugs, bowing to pressure from investor Caligan Partners ...
SAN DIEGO, Calif.—Polishing off the month of February, AMAG Technology held their 20 th annual Security Engineering Symposium (SES), focused on developing relationships, creative thinking and earning ...
HAWTHORNE, Calif. — AMAG Technology has announced the appointment of Chris Meiter as its vice president of global business development for video solutions. Meiter comes from Salient Systems, a ...
'Deck chairs on the Titanic'?: AMAG's CEO departure, drug dumps may not right the ship, analyst says
After forfeiting two board seats and undertaking a strategic review, AMAG Pharmaceuticals is saying goodbye to its CEO and two of its drugs. But with another med likely being pulled from the market, ...
WALTHAM, Mass., May 21, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced it has completed the sale of its rights to Intrarosa® (prasterone) to Millicent Pharma ...
WALTHAM, Mass., April 28, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its Board of Directors has appointed Scott Myers as AMAG’s President and Chief ...
NEW YORK, NEW YORK, UNITED STATES, January 11, 2023 /EINPresswire.com/ -- SecuritySolutionsWatch.com: Thank for joining us today, David, at this very exciting time ...
AMAG Pharmaceuticals, Inc. AMAG incurred an adjusted (excluding one-time expenses) loss of 39 cents per share in the first quarter of 2020, narrower than the year-ago reported loss of $3.32. The Zacks ...
Amid a proxy fight with activist investor Caligan Partners, AMAG Pharmaceuticals implored shareholders to stay the course on the drugmaker’s strategic vision. But with one of its drugs facing the ...
AMAG, based in Waltham, Mass., is currently struggling with the FDA to keep its drug, Makena, on the market, after an advisory board voted in October to remove it because data indicated it is ...
AMAG Pharmaceuticals, Inc. AMAG has entered into an agreement to acquire Connecticut-based privately held Perosphere Pharmaceuticals Inc., which will add the latter’s investigational candidate, ...
Forbes contributors publish independent expert analyses and insights. We write about stock options with a focus on yield. This article is more than 10 years old. Investors eyeing a purchase of AMAG ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results